G. Brittinger

CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma.

Jeanette Lundin, Anders Österborg, G. Brittinger et al. · Journal of Clinical Oncology · 1998 · 258 citations

Pharmacy, Oncology, Pharmacotherapy +16

Multicentre randomized therapeutic trial for advanced centrocytic lymphoma: Anthracycline does not improve the prognosis

P. Meusers, M. Engelhard, H. Bartels et al. · Hematological Oncology · 1989 · 172 citations

Medicine, Oncology, Pharmacology +16

Angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma: Prognostic impact of clinical observations and laboratory findings at presentation

W. Siegert, C. Nerl, Alexander G Agthe et al. · Annals of Oncology · 1995 · 131 citations · Full text

Medicine, Hematology, Oncology +17

Monoclonal antibody therapy with CAMPATH-1H in patients with relapsed high- and low-grade non-Hodgkin's lymphomas: a multicenter phase I/II study

M. Uppenkamp, Andreas Engert, Volker Diehl et al. · Annals of Hematology · 2001 · 81 citations

Pharmacy, Immunology, Oncology +16

Minichromosome maintenance protein 6, a proliferation marker superior to Ki-67 and independent predictor of survival in patients with mantle cell lymphoma

Christoph Schrader, Dirk Janssen, J.U. Siebmann et al. · British Journal of Cancer · 2005 · 69 citations · Full text

Medicine, Oncology, Pathology +17